News - AEterna Zentaris

Filter

Current filters:

AEterna Zentaris

Popular Filters

AEterna Zentaris transfers Cetrotide rights to Merck KGaA

18-04-2013

Canada's AEterna Zentaris (TSX: AEZ) says that its German subsidiary has entered into binding agreements…

AEterna ZentarisCetrotideLicensingMerck KGaAMerck SeronoPharmaceuticalReproductive

Briefs: Eddingpharm deal with GSK China for Tykerb; AEterna Zentaris and Ergomed link on AEZS-108

10-04-2013

Chinese drugmaker Eddingpharm has entered into a collaboration agreement with UK pharma giant GlaxoSmithKline's…

AEterna ZentarisAEZS-108Asia-PacificErgomed Clinical ResarchGlaxoSmithKlineLicensingOncologyPharmaceuticalResearchTykerb

AEterna Zentaris slides as it discontinues perifosine in myeloma

12-03-2013

Canada's AEterna Zentaris (TSX: AEZ) saw its stock plunge as much as 29% (closing down 22.3% at C$2.09),…

AEterna ZentarisOncologyperifosinePharmaceuticalResearch

AEterna Zentaris' perifosine seen as potential novel approach for mesothelioma

31-05-2012

Canada-based AEterna Zentaris (TSX: AEZ) has highlighted an article published in the May 2012 issue of…

AEterna ZentarisOncologyperifosinePharmaceuticalResearch

AEterna Zentaris and Keryx shares tank as cancer drug flops in Ph III

03-04-2012

Canadian drug developer AEterna Zentaris (TSX: AEZ) and US licensee Keryx Pharmaceutical (Nasdaq: KERX)…

AEterna ZentarisKeryx BiopharmaceuticalsLicensingNephrology and HepatologyOncologyperifosinePharmaceuticalResearchZerenex

Highlights of ASH meeting

13-12-2011

Among presentations at this year’s Annual Meeting of the American Society of Hematology (ASH), held…

AEterna ZentarisAriad PharmaceuticalsBiotechnologyblinatumomabMicrometOncologyperifosinePharmaceuticalPharmacyclicsponatinibResearch

AEterna Zentaris signs up Hikma to commercialize perifosine in MENA region

24-11-2011

Canada’s AEterna Zentaris (TSX: AEZ) has signed an exclusive commercialization and licensing agreement…

AEterna ZentarisGenericsHikma PharmaceuticalsLicensingOncologyperifosinePharmaceuticalRest of the World

Back to top